Skip to main navigation
Skip to search
Skip to main content
The Hebrew University of Jerusalem Home
Approve / Request updates on publications
Home
Profiles
Research units
Research output
Prizes
Search by expertise, name or affiliation
Chemotherapy of canine leishmaniosis
Gad Baneth
*
, Susan E. Shaw
*
Corresponding author for this work
The Koret School of Veterinary Medicine
Research output
:
Contribution to journal
›
Article
›
peer-review
148
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Chemotherapy of canine leishmaniosis'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Chemotherapy
100%
Canine Leishmaniosis
100%
Allopurinol
66%
Meglumine Antimoniate
66%
Visceral Leishmaniasis
33%
Mediterranean Region
33%
Middle East
33%
Immunological Parameters
33%
Dog Diseases
33%
South America
33%
Clinical Improvement
33%
Parasitological Cure
33%
Amphotericin B
33%
Fatal Infection
33%
Treatment Strategy
33%
Effective Therapy
33%
Antibody Titer
33%
Antileishmanial
33%
Cell-mediated Response
33%
New Drug Delivery Systems
33%
System Strategy
33%
Clinical Change
33%
Veterinary Science and Veterinary Medicine
Canine Leishmaniasis
100%
Dog
66%
Allopurinol
66%